HomeMy WebLinkAbout2016-08-08 16-290 Council Documents (22) Medication-Assisted Treatment(MAT) I SAMHSA Page 1 of 4
• Home Newsroom Site Map Contact Us
XSubstanatAbuse ones MAIM HaIM Undoes Admi idatrallon
ISearch SAMHSA.gov Search
Connect with SAMHSA:
Find Help & Topics Programs& Grants Data About Us Publications
Treatment Campaigns
Programs&Campaigns»Medication-Assisted Treatment(MAT) SHARE+
1
--- �- MEDICATION-ASSISTED 0 PHYSICIAN LOCATOR
TREATMENT
- OPIOID T m MENT 1
PROGRAMROGRAM DMOTORY
Medication-Assisted Treatment
(MAT)
PHARMACY LOOKUP
Medication-assisted treatment(MAT), including opioid 0
treatment programs (OTPs), combines behavioral therapy and , -5,,;,,,,,;.,z
medications to treat substance use disorders1 i
New Federal
Certifications of OTPs Buprenorphine Waiver Regulations Increase
Management Limit Rule to 275
Find directions to: Patients
To prescribe or dispense
» Apply for OTP buprenorphine, physicians
certification must qualify and apply for Physicians who have
» Notify SAMHSA of a waiver under the Drug prescribed buprenorphine to
Addiction Treatment Act of 100 patients for at least one
program changes
2000 (DATA 2000). year can now increase their
» Submit an opioid patient limits to 275 under
treatment exception Physicians can complete new federal regulations.
request the online Waiver Review the final rule in the
1 Notification Form SMA-167 Federal Register.
Regional OTP Compliance or download, complete,
Officers within SAMHSA's and fax Waiver notification The form to request the
Division of Pharmacologic Form SMA-167 (PDF 162 higher limit is not yet
Therapies (DPT) determine KB) to 240-238-9858. available. To receive the
whether an OTP is qualified form and guidance
to carry out opioid Physicians are also required information, contact the
treatment. to complete buprenorphine SAMHSA Center for
1 II training. Substance Abuse Treatment
(CSAT) at
info@abuprenorphine.samhsa.gov.
http://www.samhsa.gov/medication-assisted-treatment 7/18/2016
Medication-Assisted Treatment(MAT) 1 SAMHSA Page 2 of 4
Oversight of OTP Learn more about how to: Please include your contact
Accrediting Bodies „ Apply to increase information, your data
Ill
waiver number and patient
SAMHSA appoints eligible patient limits limit, and a statement
nonprofit organizations and » Update physician affirming your 100 patient
governmental entities to be contact information certification for at least one
OTP accrediting bodies. year.
Verify physician waivers
(for pharmacists)
Access Form SMA-163: For more information, send
Application for Approval as an email or call 866-BUP-
Accreditation Body. Physicians can join the CSAT(866-287-2728).
SAMHSA Buprenorphine
Find contact information for Clinical Discussion
existing SAMHSA-Approved WebBoard to ask and
OTP Accrediting Bodies. discuss questions on the Publications
clinical use of
buprenorphine. » 2014 Buprenorphine
Training Materials and Summit: Report of
Provider Resources Proceedings(PDF 13
Medication and MB)
» Buprenorphine training Counseling Treatment » Medication-Assisted
for physicians
Treatment for Opioid
» Opioid prescribing A combination of Addiction: Facts for
courses for physicians medication and counseling Families and Friends—
and behavioral therapy is 2009
» Webinars, workshops, effective in treating alcohol
and summits and opioid dependency. » Federal Guidelines for •
» Publications and Opioid Treatment
research Learn about the different Programs—2015
» Support organizations medications used in MAT: » Medication-Assisted
Treatment of Alcohol
» Buprenorphine Use Disorder—2015
» Methadone
Legislation, » TIP 40: Clinical
Regulations, and » Naltrexone Guidelines for the Use
Guidelines » Naloxone (for opioid of Buprenorphine—
overdose) 2004
MAT for opioid addiction is
subject to federal
legislation, regulations, and Find information on Related SAMHSA
guidelines, including DATA physical ailments often Resources
2000 and federal regulation diagnosed in MAT patients.
42 CFR 8. Also known as common » Behavioral Health
comorbidities, these include Treatments and
SAMHSA's Dear Colleague viral hepatitis, HIV, and Services
Letters offer providers of AIDS. » Medical Records Privacy
MAT services guidance on and Confidentiality
emerging issues related to
Physician and Program
opioid treatment.
» Mental and Substance
Data Use Disorders
Access Model Guidelines for Under DATA 2000, » Prescription Drug Misuse IP
State Medical Boards. SAMHSA: and Abuse
http://www.samhsa.gov/medication-assisted-treatment 7/18/2016
Medication-Assisted Treatment(MAT) I SAMHSA Page 3 of 4
Learn more about special » Evaluates the
circumstances for providing buprenorphine waiver Contact Us
buprenorphine. program
» Presents a breakdown For information on
of U.S. DATA-certified buprenorphine treatment,
physicians providing contact the SAMHSA Center
buprenorphine for Substance Abuse
treatment Treatment(CSAT) at 866-
» Tracks the number of BUP-CSAT(866-287-2728)
certified physicians by or
state info@buprenorphine.samhsa.gov.
For information about other
About DPT medication-assisted
treatment(MAT) or the
DPT oversees the certification of opioid
dispensation of controlled treatment programs (OTPs),
narcotic medications for the contact the SAMHSA Division
treatment of substance use of Pharmacologic Therapies
disorders. at 240-276-2700 or otp-
extranet@opioid.samhsa.gov.
Contact SAMHSA's regional
Last Updated: 05/23/2016 OTP Compliance Officers to
411 determine if an OTP is
qualified to provide
treatment for substance use
disorders.
SAMHSA.gov Strategic About Us
Homepage Initiatives
Find Help
Accessibility Health
Publications
Financing
Privacy
Newsroom
Prevention
Disclaimer
Budget
Treatment
Viewers & Plugins
Data
Recovery — —
FOIA
Grants
Other
Plain Language - -
Topics J
http://www.samhsa.gov/medication-assisted-treatment 7/18/2016
Medication-Assisted Treatment(MAT) I SAMHSA Page 4 of 4
Site Map Grant
Awards
•
SAMHSA Archive
SAMHSA's mission is to reduce the impact
of substance abuse and mental illness on — —
America's communities.
5600 Fishers Ln . Rockville, MD 20857
1-877-SAMHSA-7(1-877-726-4727)
•
•
http://www.samhsa.gov/medication-assisted-treatment 7/18/2016